Botulinum Toxin Market cover

Botulinum Toxin Market by Types (Botulinum Toxin Type A and Botulinum Toxin Type B), End-users (Aesthetic and Therapeutics), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2337
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 43
  • No. Of Pages: 193
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global botulinum toxin market size is projected to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing demand for non-invasive or invasive therapeutic procedures for eye disorders.

Botulinum Toxin Market summary

Botulinum toxin can be understood as a type of neurotoxic protein that is produced by bacterium called clostridium botulinum and associated species. It primarily causes a range of eye disorders due to the development of the disease, impacted by muscle stiffness around cervical areas. This is also used for cosmetic and medical purposes, which are available of seven different forms i.e. botulinum toxin - A, B, C, D, E, F, and G. Most of these toxins are processed by anaerobic bacterium, which is largely used for aesthetic purposes. Large investments in research & development projects to develop the therapeutic use of the toxin are generating opportunities for the expansion of its application in various medical fields.

However, issues concerning such as reverse effects such as rash, neck and back pain, and nausea are key factors effecting the acceptance of neurotoxins in cosmetic application and therapeutics. Additionally, huge cost involve in performing such expensive procedures and poor reimbursement coverage are expected to negatively affect the market. Meanwhile, the COVID-19 situation has also effected to market negatively as all the non-urgent or non-COVID related-medical facilities were shut down due to lockdown restrictions.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising demand for minimally non-invasive or invasive procedures for the disease treatment are the factors fueling the growth of the global market.
  • Huge investments in research and development projects to develop the therapeutic use of botulinum toxin is expected to create opportunities for its application area in the coming years.
  • Increasing social awareness regarding the commercial availability of these products is expected to boost the growth of the market.
  • Side effects such as allergic reactions, and shortness of breath are expected to hamper the acceptance of neurotoxins in cosmetic and therapeutics application. 
  • High cost for the therapeutic procedures and lack of a proper remuneration system are further expected to hamper the market growth.

Scope of the Report                         

The report on the global botulinum toxin market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Botulinum Toxin Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Botulinum Toxin Type A and Botulinum Toxin Type B) and End-users (Aesthetic and Therapeutics)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Ipsen Group; Allergan, Inc.; Revance Therapeutics, Inc.; Merz Pharma GmbH and Co. KGaA; Medytox, Inc.; Lanzhou Institute of Biological Products Co. Ltd.; and US Worldmed, LLC.

Market Segment Insights

Botulinum toxin type A segment is expected to grow at a rapid pace

Based on types, the global botulinum toxin market is bifurcated into botulinum toxin type A and botulinum toxin type B. The botulinum toxin type A segment accounted for a key share of the market in 2019 and is expected to grow at a rapid pace during the projected period owing to minimal side effects of using the product types. However, the botulinum toxin type B segment is anticipated to witness substantial growth in the coming years due to low cost and easy availability.

Botulinum Toxin Market type

Aesthetic segment is projected to expand at a considerable CAGR

On the basis of end-users, the market is divided into aesthetic and therapeutics. The aesthetic segment is projected to expand at a considerable CAGR during the forecast period due to increase in the number of research and development activities related to aesthetic applications. Meanwhile, the therapeutics segment is anticipated to expand at a robust growth rate during the forecast period owing to rising demand for therapeutic techniques.

North America is anticipated to constitute a key market share

In terms of regions, the global botulinum toxin market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to constitute a key share of the market in the coming years owing to variety of aesthetic procedures. The market of Asia Pacific, meanwhile, is anticipated to expand at a fast growth pace during the forecast period due to growing social awareness regarding the products availability.

Botulinum Toxin Market region

Segments

Segments Covered in the Report

The global botulinum toxin market has been segmented on the basis of

Types

  • Botulinum Toxin Type A
  • Botulinum Toxin Type B

 End-users

  • Aesthetic
  • Therapeutics

 Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Ipsen Group
  • Allergan, Inc.
  • Revance Therapeutics, Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Medytox, Inc.
  • Lanzhou Institute of Biological Products Co. Ltd.
  • US Worldmed, LLC.

Competitive Landscape

Key players competing in the global botulinum toxin market are Ipsen Group; Allergan, Inc.; Revance Therapeutics, Inc.; Merz Pharma GmbH and Co. KGaA; Medytox, Inc.; Lanzhou Institute of Biological Products Co. Ltd.; and US Worldmed, LLC. The main market players are continuously engaged in a range of business development activities such as mergers and acquisitions, research and developments, investments for innovative products, and collaborations to enhance their market share.

Botulinum Toxin Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Botulinum Toxin Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Botulinum Toxin Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Botulinum Toxin Market - Supply Chain
  4.5. Global Botulinum Toxin Market Forecast
     4.5.1. Botulinum Toxin Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Botulinum Toxin Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Botulinum Toxin Market Absolute $ Opportunity
5. Global Botulinum Toxin Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Botulinum Toxin Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Botulinum Toxin Demand Share Forecast, 2019-2026
6. North America Botulinum Toxin Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Botulinum Toxin Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Botulinum Toxin Demand Share Forecast, 2019-2026
7. Latin America Botulinum Toxin Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Botulinum Toxin Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Botulinum Toxin Demand Share Forecast, 2019-2026
8. Europe Botulinum Toxin Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Botulinum Toxin Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Botulinum Toxin Demand Share Forecast, 2019-2026
9. Asia Pacific Botulinum Toxin Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Botulinum Toxin Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Botulinum Toxin Demand Share Forecast, 2019-2026
10. Middle East & Africa Botulinum Toxin Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Botulinum Toxin Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Botulinum Toxin Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Botulinum Toxin Market: Market Share Analysis
  11.2. Botulinum Toxin Distributors and Customers
  11.3. Botulinum Toxin Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Ipsen Group
     11.4.2. Allergan, Inc.
     11.4.3. Revance Therapeutics, Inc.
     11.4.4. Merz Pharma GmbH and Co. KGaA
     11.4.5. Medytox, Inc.
     11.4.6. Lanzhou Institute of Biological Products Co. Ltd.
     11.4.7. US Worldmed, LLC.

Segments Covered in the Report

The global botulinum toxin market has been segmented on the basis of

Types

  • Botulinum Toxin Type A
  • Botulinum Toxin Type B

 End-users

  • Aesthetic
  • Therapeutics

 Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Ipsen Group
  • Allergan, Inc.
  • Revance Therapeutics, Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Medytox, Inc.
  • Lanzhou Institute of Biological Products Co. Ltd.
  • US Worldmed, LLC.

Key players competing in the global botulinum toxin market are Ipsen Group; Allergan, Inc.; Revance Therapeutics, Inc.; Merz Pharma GmbH and Co. KGaA; Medytox, Inc.; Lanzhou Institute of Biological Products Co. Ltd.; and US Worldmed, LLC. The main market players are continuously engaged in a range of business development activities such as mergers and acquisitions, research and developments, investments for innovative products, and collaborations to enhance their market share.

Botulinum Toxin Market keyplayers

Buy Report